Skip to main content
OpenTrials
Completed

NCT Number: NCT06417671

The Effect of Postbiotics Supplementation on Exercise-induced Oxidative Stress.

Scientific data on the effect of supplementation of postbiotics on exercise-induced oxidative stress are scarce. The main purpose of the research is to investigate the effect of postbiotics supplementation on exercise-induced oxidative stress and performance indicators after intense exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Participants will be randomly assigned into one of the two trials: i) Postbiotics supplementation for 4 weeks, ii) Placebo supplementation for 4 weeks. Participants will then perform a 45-min treadmill running at (-15% slope, ~70% VO2max) followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before, as well as 24 h, 48 h and 72 h after the exercise, participants will undergo measurements of exercise-induced muscle damage (EIMD) [delayed onset of muscle soreness (DOMS), creatine kinase], blood redox status [total antioxidant capacity, catalase, protein carbonyls, reduced glutathione, oxidized glutathione], and isokinetic performance (knee-extensors and knee-flexors isometric, concentric, eccentric torque) evaluation. In addition, metabolism (lactic acid) will be assessed before and 4 min after exercise. Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, blood redox status and performance indices at the same time-points. At the second cycle, the participants will repeat the above procedures under the remaining condition. Between conditions, there will be a 14-day washout period. The results of the research will provide important information for coaches and physically active individuals, regarding the effectiveness of postbiotics in alleviating oxidative stress and improving performance after intense exercise.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Physical Education and Sport Science, Uninersity of Thessaly

Trikala, Thessaly, 42100, Greece

About this study

Acute, vigorous and/or unaccustomed exercise can induce muscle injury and oxidative stress. At moderate concentrations, reactive oxygen and nitrogen species (RONS) act as signaling molecules and promote adaptations to systematic training. Conversely, excessive production of RONS may cause destructive effects, due to the oxidation of important biomolecules such as lipids and proteins, but also DNA. Disruption of the redox balance can bring about adverse effects on exercise-induced adaptations, such as muscle damage and fatigue. For this reason, many professional as well as amateur athletes, often consume nutritional supplements such as antioxidants, anticipating to reduce inflammation and oxidative stress after intense exercise.

The human gastrointestinal tract is inhabited by various microorganisms, called the gut microbiome (GM). GM, among other things, contributes to the normal functioning of the immune system, contributes to the production of short-chain fatty acids (SCFAs) and vitamin synthesis as well as the digestion and absorption of food, protects against enteropathogens and regulates inflammatory and redox responses. Recent evidence also suggests that GM may be involved in athletic performance. In contrast, disruption of GM composition (dysbiosis) is characterized by reduced diversity, reduced abundance of health-promoting bacteria, and increased abundance of gram-negative and other pathogenic bacteria and is associated with various metabolic diseases such as obesity, diabetes, and various forms of cancer, systemic inflammation, oxidative stress and reduced performance. Thus, the supplementation of several "biotics" has been emerged as a means to regulate the GM in favor of health-promoting bacteria.

Postbiotics is defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Evidence suggests that supplementation with postbiotics may regulate the GM, and consequently, strengthen the immune system, reduce intestinal permeability, improve antioxidant mechanisms, as well as accelerate recovery after exercise-induced inflammation, enhance adaptations to exercise, and improve performance. However, the scientific data regarding the possible beneficial effect of supplemental administration of postbiotics is limited. More research is needed, in order to determine the role of postbiotics supplementation on exercise-induced inflammation and redox status, but also on performance after intense exercise.

This study will investigate the potential of postbiotics supplementation to affect the recovery of exercise-induced oxidative stress and performance following intense, eccentrically biased acute exercise.

The study will be cross-over, randomized, double-blind, controlled, and will be conducted in two cycles. The participants, will be primarily informed of the study procedures, as well as the benefits and possible risks, they will also sign an informed consent form for participation in the study. Before the experimental procedure, they will be involved in a week of familiarization to the evaluation tests and the exercise protocol, at a low intensity. In addition, the participants will record their diet via a 7-days recall before their participation in the first experimental condition, and dietary data will be analyzed with ScienceFit Diet 200A diet analysis program (Science Technologies, Athens, Greece), in order to estimate that they do not consume nutrients that may affect muscle injury, inflammation and oxidative stress (e.g. antioxidants, etc.). Baseline measurements will take place at the Laboratory of Biochemistry, Physiology and Nutrition of Exercise (SmArT Lab), Department of Physical Education and Sports, University of Thessaly: anthropometric characteristics (body height, body mass, body mass index) via a stadiometer-scale (Stadiometer 208; Seca, Birmingham, UK), body composition (amount of body fat, lean body mass, fat mass, bone density) via by dual emission X-ray absorptiometry (DXA, GE-Healthcare, Lunar DPX NT, Belgium), aerobic capacity (VO2max) via an automated online pulmonary gas analyzer (Vmax Encore 29, BEBJO296, Yorba Linda, CA, USA) during a graded exercise protocol on a treadmill (Stex 8025T, Korea), isokinetic strength (isometric, concentric and eccentric torque of the knee extensors and knee flexors) on an isokinetic dynamometer (Cybex, HUMAC NORM 360, Ronkonkoma, NY), and muscle power via the assessment of countermovement jump (CMJ) via an optical measurement system (Optojump next, Microgate, USA). Participants will then be randomized in one of the two conditions: i) Postbiotics supplementation (50mg/day of Heat-killed Lactobacillus plantarum L-137, Immuno-LP20TM) for 4 weeks, or ii) placebo supplementation for 4 weeks. Randomization of the conditions will be done by a software generating random integers available on the internet (Random.org). Seven days later, participants will perform an exercise protocol comprised of 45 min downhill running (-15% slope, ~70-75% VO2max) on a treadmill followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before the exercise protocol, as well as 24 h, 48 h and 72 h after exercise, delayed onset of muscle soreness (DOMS) via palpation of the knee extensors and knee flexors on a scale of 1 to 10 (1 = no pain at all; 10 = extreme pain), and muscle performance (CMJ, isometric, concentric and eccentric torque of the knee extensors and knee flexors) will be assessed. Additionally, blood samples will be collected at the same time-points for the assessment of creatine kinase (CK), and blood redox status [reduced glutathione (GSH), oxidized glutathione (GSSG), GSH/GSSG ratio, total antioxidant capacity (TAC), catalase (CAT), protein carbonyls (PC), uric acid, bilirubin)]. Furthermore, metabolism (lactic acid) will be assessed before and 4 min after exercise by analyzing capillary blood with a portable lactate analyzer (Lactate Plus, Nova Biomedical, USA). After a 14-days washout period, participants will repeat the exact same procedures for the remaining condition in the second cycle. Additionally, the 7-day diet recall will be given to the participants to follow the same diet before the experimental exercise protocol at the second cycle.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Physically active subjects (VO2max ≥35ml/kg/min)
  • Absence of musculoskeletal injury (≥6 months)
  • Abstinence from the use of ergogenic supplements (≥1 month)
  • Abstinence from anti-inflammatory drugs (≥1 month)
  • Abstinence from pre-pro-postbiotic supplements (≥6 months)
  • Abstinence from participating in exercise with eccentric content for at least 7 days before exercise
  • Abstinence from alcohol and energy drinks before exercise

Exclusion criteria

  • Recent history of musculoskeletal injury (<6 months)
  • Use of ergogenic performance supplements (<1 month)
  • Taking anti-inflammatory drugs (<1 month)
  • Taking pre-pro-postbiotic supplements (<6 months)
  • Participation in exercise with eccentric content in the previous 7 days before exercise
  • Consumption of alcohol and energy drinks before exercise

Treatment and study plan

Postbiotics supplementation

Dietary Supplement

The participants will consume one capsule per day.

Placebo supplementation

Dietary Supplement

The participants will consume one capsule per day.

Primary outcomes

  1. Changes in PC

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of PC will be measured in plasma

  2. Changes in malondialdehyde (MDA)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of MDA will be measured in plasma

  3. Changes in reduced glutathione (GSH)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of GSH will be measured in red blood cells

  4. Changes in oxidized glutathione (GSSG)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of GSSG will be measured in red blood cells

  5. Changes in GSH/GSSG ratio

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    GSH/GSSG ratio will be calculated

  6. Changes in catalase

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of catalase will be measured in red blood cells

  7. Changes in total antioxidant capacity (TAC)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    TAC will be measured in plasma

  8. Changes in uric acid

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of uric acid will be measured in plasma

  9. Changes in bilirubin

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Concentration of bilirubin will be measured in plasma

  10. Changes in blood lactate

    Time frame: At baseline (pre), and 4 min post-trial

    Concentration of lactate will be measured in capillary blood

  11. Changes in in delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Muscle soreness of the KF and KE will be assessed via palpation of the muscle belly and the distal regions following 3 squats, and the subjective pain will be recorded on a 10-point scale (1 = no pain, 10 = extreme pain)

  12. Changes in creatine kinase (CK)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    CK will be will be measured in serum

  13. Changes in countermovement jump (CMJ) height

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    CMJ height will be measured with an optical system

  14. Changes in isokinetic strength of knee extensors (KE) and knee flexors (KF)

    Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

    Isometric, concentric and eccentric peak torque of the KE and KF of both limbs will be assessed on an isokinetic dynamometer

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Acronym: PB-EIOS

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
May 16, 2024
Registry last updated
Dec 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.